Site içinde arama yapın

Shweta Kadam bir ses eklendi Other
2025-06-06 03:40:57 -

Neurology Small Molecule API Market Overview: Growth, Share, Value, Size, and Scope
"Executive Summary: The neurology small molecule API market is experiencing significant growth driven by increasing neurological disorders, a rising geriatric population, and advancements in drug development. A major new study published in The Lancet Neurology reveals that, in 2021, over 3 billion people globally were living with a...

0 Yorumlar 0 hisse senetleri 57 Views 0 önizleme

Please log in to like, share and comment!
Vaibhav Gaikwad bir ses eklendi Other
2025-04-07 08:04:37 -

Small Molecule Injectable Drugs Market Trends, Growth, and Forecast 2030
Small molecule injectable drugs remain vital in treating various conditions such as cancer, infections, blood, and cardiovascular diseases, even as biologics grow. These injectables are often necessary for rapid therapeutic effects, especially in emergencies or when patients can’t take oral medications. Delivered directly into the bloodstream, they ensure fast and effective...

0 Yorumlar 0 hisse senetleri 551 Views 0 önizleme

Please log in to like, share and comment!
Data Bridge bir ses eklendi Other
2025-05-09 05:25:11 -

Urology Small Molecule API Market projected to reach USD 2.86 billion by 2032
The Urology Small Molecule API Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2032. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and...

0 Yorumlar 0 hisse senetleri 222 Views 0 önizleme

Please log in to like, share and comment!
Kislay Kumar bir ses eklendi Other
2025-05-19 13:49:52 -

Advanced Non-Squamous and Squamous NSCLC Market is driven by immunotherapy adoption
The Advanced Non-Squamous and Squamous NSCLC Market encompasses a broad portfolio of targeted therapies, immune checkpoint inhibitors, and next-generation diagnostics designed to improve patient outcomes in both histological subtypes of non-small cell lung cancer. Products such as PD-1/PD-L1 inhibitors, EGFR tyrosine kinase inhibitors, and novel bispecific antibodies help address treatment...

0 Yorumlar 0 hisse senetleri 240 Views 0 önizleme

Please log in to like, share and comment!
Daisyjohnson Johnson bir ses eklendi Other
2025-06-03 09:41:02 -

EGFR Inhibitors Market Advances with Growing Applications in Targeted Cancer Therapies
"Global Epidermal Growth Factor Receptor Inhibitors Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global epidermal growth factor receptor inhibitors market size was valued at USD 14.10 billion in 2024 and is projected to reach USD 28.10 billion by 2032, with a CAGR of 9.00% during the forecast period of 2025 to 2032....

0 Yorumlar 0 hisse senetleri 107 Views 0 önizleme

Please log in to like, share and comment!
Daisyjohnson Johnson bir ses eklendi Other
2025-05-15 08:37:21 -

EGFR Inhibitors Market Strengthens Amid Rising Cancer Incidence and Breakthrough Targeted Therapies
"Epidermal Growth Factor Receptor Inhibitors Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 According to Data Bridge Market Research firms, the EGFR Targeted Therapies is set to achieve robust growth, supported by emerging economies and digital transformation. Companies operating in the Cancer Growth Receptor Blockers are leveraging...

0 Yorumlar 0 hisse senetleri 233 Views 0 önizleme

Please log in to like, share and comment!